These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 18217599)
1. Target-selective degradation of proteins by a light-activated 2-phenylquinoline-estradiol hybrid. Suzuki A; Tsumura K; Tsuzuki T; Matsumura S; Toshima K Chem Commun (Camb); 2007 Nov; (41):4260-2. PubMed ID: 18217599 [TBL] [Abstract][Full Text] [Related]
2. Molecular design, chemical synthesis, and biological evaluation of agents that selectively photo-degrade the transcription factor estrogen receptor-α. Tsumura K; Suzuki A; Tsuzuki T; Tanimoto S; Kaneko H; Matsumura S; Imoto M; Umezawa K; Takahashi D; Toshima K Org Biomol Chem; 2011 Sep; 9(18):6357-66. PubMed ID: 21789304 [TBL] [Abstract][Full Text] [Related]
3. 2-Phenylquinoline-Sugar Hybrids as Photoswitchable α-Glucosidase Inhibitors. Kitamura T; Okuyama M; Takahashi D; Toshima K Chem Asian J; 2019 May; 14(9):1409-1412. PubMed ID: 30859722 [TBL] [Abstract][Full Text] [Related]
4. Chemical methods for degradation of target proteins using designed light-activatable organic molecules. Tanimoto S; Takahashi D; Toshima K Chem Commun (Camb); 2012 Aug; 48(62):7659-71. PubMed ID: 22739361 [TBL] [Abstract][Full Text] [Related]
5. Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid. Tanimoto S; Sakai S; Matsumura S; Takahashi D; Toshima K Chem Commun (Camb); 2008 Nov; (44):5767-9. PubMed ID: 19009075 [TBL] [Abstract][Full Text] [Related]
6. Target-selective degradation of proteins by porphyrins upon visible photo-irradiation. Tanimoto S; Matsumura S; Toshima K Chem Commun (Camb); 2008 Aug; (31):3678-80. PubMed ID: 18665297 [TBL] [Abstract][Full Text] [Related]
7. Target-selective degradation of proteins and oligosaccharides by light-activated hybrid molecules for molecular-targeted photodynamic therapy. Toshima K Future Med Chem; 2009 Sep; 1(6):1113-24. PubMed ID: 21425996 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates. Ahmed N; Dubuc C; Rousseau J; Bénard F; van Lier JE Bioorg Med Chem Lett; 2007 Jun; 17(11):3212-6. PubMed ID: 17379515 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues. Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414 [TBL] [Abstract][Full Text] [Related]
10. Identification of covalent attachment site of antiestrogenic estradiol 11 beta-derivatives on human estrogen receptor alpha ligand-binding domain. Aliau S; Mattras H; Borgna JL J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):111-21. PubMed ID: 16439113 [TBL] [Abstract][Full Text] [Related]
11. Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators. Wittmann BM; Sherk A; McDonnell DP Cancer Res; 2007 Oct; 67(19):9549-60. PubMed ID: 17909066 [TBL] [Abstract][Full Text] [Related]
12. Fluorous tolerance of the estrogen receptor alpha as probed by 11-polyfluoroalkylestradiol derivatives. Agouridas V; Blazejewski JC; Cleeren A; Laïos I; Leclercq G; Magnier E Steroids; 2008 Mar; 73(3):320-7. PubMed ID: 18177682 [TBL] [Abstract][Full Text] [Related]
13. Degradation of target oligosaccharides by anthraquinone-lectin hybrids with light switching. Imai Y; Hirono S; Matsuba H; Suzuki T; Kobayashi Y; Kawagishi H; Takahashi D; Toshima K Chem Asian J; 2012 Jan; 7(1):97-104. PubMed ID: 21997955 [TBL] [Abstract][Full Text] [Related]
14. 3D model of amphioxus steroid receptor complexed with estradiol. Baker ME; Chang DJ Biochem Biophys Res Commun; 2009 Aug; 386(3):516-20. PubMed ID: 19540191 [TBL] [Abstract][Full Text] [Related]
15. Target-selective photo-degradation of verotoxin-1 and reduction of its cytotoxicity to Vero cells using porphyrin-globotriose hybrids. Okochi A; Tanimoto S; Takahashi D; Toshima K Chem Commun (Camb); 2013 Jul; 49(54):6027-9. PubMed ID: 23722161 [TBL] [Abstract][Full Text] [Related]
16. Ligand-selective interdomain conformations of estrogen receptor-alpha. Padron A; Li L; Kofoed EM; Schaufele F Mol Endocrinol; 2007 Jan; 21(1):49-61. PubMed ID: 17008385 [TBL] [Abstract][Full Text] [Related]
17. Degradation of endocrine disrupting chemicals bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation processes. Rosenfeldt EJ; Linden KG Environ Sci Technol; 2004 Oct; 38(20):5476-83. PubMed ID: 15543754 [TBL] [Abstract][Full Text] [Related]
18. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties. Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer. Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351 [TBL] [Abstract][Full Text] [Related]
20. The removal of estrogenic activity with UV/chlorine technology and identification of novel estrogenic disinfection by-products. Li M; Xu B; Liungai Z; Hu HY; Chen C; Qiao J; Lu Y J Hazard Mater; 2016 Apr; 307():119-26. PubMed ID: 26780699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]